GNVC: Q2 Earnings Call @ 10:00 ET Today [delayed] -
GenVec Reports Second Quarter 2008 Financial Results -
GenVec Announces Second Quarter 2008 Results Conference Call -
GNVC: Awarded $6.6M Option from Dept of Homeland Security for Vaccine Program -
GenVec Receives Continued Funding from the U.S. Department of Homeland Security for Vaccine Program -
GenVec Inc reports offering of common shares -
GNVC: $17M Private Placement of Common Stock + Warrants -
GenVec Announces Registered Offering of $17 Million in Common Stock and Warrants -
GNVC: Presents Positive Ph I Data re TNFerade(TM) in Head and Neck Cancer -
Encouraging Findings from TNFerade(TM) Head and Neck Cancer Study Presented at ASCO -
GenVec Jumps In Pre-Market On Positive Trial Results For New Cancer Treatment -
GNVC: Presents Update Today re Ph II Trial of TNFerade(TM) in Esophageal Cancer -
GenVec Presents Encouraging Data on TNFerade(TM) in Esophageal Cancer -
GNVC: Receives $546K Grant from National Eye Institute -
GenVec receives $546,000 grant for PEDF program -
GenVec Receives Grant for PEDF Program -
GenVec Inc. (GNVC) Corporate Event Announcement Notice -
GNVC: Q1 Earnings Call @ 10:00 ET Today [delayed] -
GenVec Inc. (GNVC) Corporate Event Announcement Notice -
GenVec Inc receives SBIR grant for RSV vaccine programme -